Natera Share Holder Equity 2014-2023 | NTRA
Natera share holder equity from 2014 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
- Natera share holder equity for the quarter ending December 31, 2023 was $0.765B, a 8.44% increase year-over-year.
- Natera share holder equity for 2023 was $0.765B, a 8.44% increase from 2022.
- Natera share holder equity for 2022 was $0.706B, a 8.03% increase from 2021.
- Natera share holder equity for 2021 was $0.653B, a 34.36% increase from 2020.
| Natera Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2023 | $765 |
| 2022 | $706 |
| 2021 | $653 |
| 2020 | $486 |
| 2019 | $279 |
| 2018 | $32 |
| 2017 | $25 |
| 2016 | $106 |
| 2015 | $185 |
| 2014 | $69 |
| 2013 | $14 |
| Natera Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2023-12-31 | $765 |
| 2023-09-30 | $785 |
| 2023-06-30 | $596 |
| 2023-03-31 | $651 |
| 2022-12-31 | $706 |
| 2022-09-30 | $362 |
| 2022-06-30 | $445 |
| 2022-03-31 | $542 |
| 2021-12-31 | $653 |
| 2021-09-30 | $759 |
| 2021-06-30 | $299 |
| 2021-03-31 | $372 |
| 2020-12-31 | $486 |
| 2020-09-30 | $536 |
| 2020-06-30 | $304 |
| 2020-03-31 | $259 |
| 2019-12-31 | $279 |
| 2019-09-30 | $85 |
| 2019-06-30 | $93 |
| 2019-03-31 | $5 |
| 2018-12-31 | $32 |
| 2018-09-30 | $57 |
| 2018-06-30 | $-22 |
| 2018-03-31 | $-4 |
| 2017-12-31 | $25 |
| 2017-09-30 | $30 |
| 2017-06-30 | $51 |
| 2017-03-31 | $74 |
| 2016-12-31 | $106 |
| 2016-09-30 | $140 |
| 2016-06-30 | $164 |
| 2016-03-31 | $182 |
| 2015-12-31 | $185 |
| 2015-09-30 | $206 |
| 2015-06-30 | $43 |
| 2015-03-31 | $0 |
| 2014-12-31 | |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2013-12-31 | $14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.711B | $1.083B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $122.475B | 15.37 |
| Cencora (COR) | United States | $44.674B | 17.41 |
| ICON (ICLR) | Ireland | $25.493B | 24.07 |
| DiDi Global (DIDIY) | China | $24.448B | 0.00 |
| Avantor (AVTR) | United States | $16.791B | 24.72 |
| Viatris (VTRS) | United States | $14.026B | 4.03 |
| CochLear (CHEOY) | Australia | $13.917B | 0.00 |
| Revvity (RVTY) | United States | $12.428B | 21.78 |
| Medpace Holdings (MEDP) | United States | $12.163B | 40.02 |
| Charles River Laboratories (CRL) | United States | $12.026B | 21.92 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.540B | 0.00 |
| Solventum (SOLV) | United States | $11.153B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.297B | 0.00 |
| HealthEquity (HQY) | United States | $6.740B | 50.35 |
| Organon (OGN) | United States | $5.043B | 4.78 |
| Bausch + Lomb (BLCO) | Canada | $4.779B | 19.15 |
| Doximity (DOCS) | United States | $4.494B | 33.46 |
| PACS (PACS) | United States | $3.725B | 0.00 |
| Sotera Health (SHC) | United States | $3.119B | 15.31 |
| Surgery Partners (SGRY) | United States | $3.118B | 28.86 |
| Progyny (PGNY) | United States | $3.049B | 51.16 |
| GoodRx Holdings (GDRX) | United States | $2.804B | 142.00 |
| Life Times (LTH) | United States | $2.783B | 29.48 |
| Premier (PINC) | United States | $2.460B | 9.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.256B | 7.30 |
| Teladoc Health (TDOC) | United States | $2.167B | 0.00 |
| Agilon Health (AGL) | United States | $1.985B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.969B | 0.00 |
| NovoCure (NVCR) | Jersey | $1.590B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.451B | 0.00 | |
| Agiliti (AGTI) | United States | $1.374B | 22.44 |
| Alignment Healthcare (ALHC) | United States | $1.264B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.784B | 8.11 |
| Embecta (EMBC) | United States | $0.584B | 3.86 |
| InnovAge Holding (INNV) | United States | $0.549B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.528B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.512B | 0.00 |
| LifeMD (LFMD) | United States | $0.512B | 0.00 |
| Enhabit (EHAB) | United States | $0.511B | 46.27 |
| CareDx (CDNA) | United States | $0.503B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.480B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.463B | 0.00 |
| MultiPlan (MPLN) | United States | $0.422B | 0.00 |
| Beauty Health (SKIN) | United States | $0.415B | 0.00 |
| ModivCare (MODV) | United States | $0.383B | 7.18 |
| DocGo (DCGO) | United States | $0.376B | 60.17 |
| Sera Prognostics (SERA) | United States | $0.352B | 0.00 |
| Sharecare (SHCR) | United States | $0.270B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.265B | 0.00 |
| Biodesix (BDSX) | United States | $0.161B | 0.00 |
| So-Young (SY) | China | $0.128B | 43.00 |
| Oncology Institute (TOI) | United States | $0.080B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.075B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| NeueHealth (NEUE) | United States | $0.051B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
| Nutex Health (NUTX) | United States | $0.034B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| OncoCyte (OCX) | United States | $0.022B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |